Related references
Note: Only part of the references are listed.Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
Qian Ba et al.
PLOS ONE (2012)
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Ya He et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Toxicity of the antimalarial artemisinin and its dervatives
Thomas Efferth et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Anticancer activities of artemisinin and its bioactive derivatives
Gary L. Firestone et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester
Robert L. Clark
REPRODUCTIVE TOXICOLOGY (2009)
Artesunate: Developmental toxicity and toxicokinetics in monkeys
Robert L. Clark et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Ikuhiko Nakase et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C
Jun Wang et al.
PHARMACOLOGY (2008)
Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)
Monica Longo et al.
REPRODUCTIVE TOXICOLOGY (2008)
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Hui-Jun Zhou et al.
VASCULAR PHARMACOLOGY (2007)
Vascular endothelial growth factor: Biology and therapeutic applications
Quoc T. Ho et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos
Monica Longo et al.
REPRODUCTIVE TOXICOLOGY (2006)
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
J Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
VEGF-PLCγ1 pathway controls cardiac contractility in the embryonic heart
W Rottbauer et al.
GENES & DEVELOPMENT (2005)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit
RL Clark et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2004)
The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies
M Wartenberg et al.
LABORATORY INVESTIGATION (2003)
Artemisinin: mechanisms of action, resistance and toxicity
SR Meshnick
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development
D Liang et al.
MECHANISMS OF DEVELOPMENT (2001)
Share Paper
